ArticleNeuro-oncology advances

Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.

Louis Larrouquere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.